Press release
Balantidiasis Market Research and Development Strategy 2019 by Leading Industry Players - Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG
Market Synopsis of the Global Balantidiasis Market
Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human. Improper sanitary conditions and unsafe drinking water are important aspects for the spread of the diseases.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4725
The market is driven by the increasing prevalence of communicable diseases in rural areas for developing countries.
In addition, increasing research and development activities, technological advancements to identify the causes and risk factors for transmission of infectious agents and developing new solutions to minimize patient exposure is another major driver, fuelling the global market growth.
The global balantidiasis market is expected to grow at a CAGR of 2.1% during the forecast period.
Key Players in the Global Balantidiasis Market
Some of the key players in this market are Pfizer (U.S.)
Abbott (U.S.)
GlaxoSmithKline plc. (U.K)
BD (U.S.)
Sandoz International GmbH (Germany)
Amneal Pharmaceuticals LLC. (U.S.)
Akorn, Inc. (U.S.)
PharmaDerm, a division of Fougera Pharmaceuticals Inc. (U.S.).
Segments of the Global Balantidiasis Market
The global balantidiasis market is segmented on the basis of diagnosis, treatment, and end user.On the basis of diagnosis, the market is segmented into stool examination, sigmoidoscopy, biopsy, and others.
On the basis of treatment, the market is segmented into antibiotics, appendectomy, and others. Antibiotics segment is further divided into tetracycline, metronidazole, and others.On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.
Regional Analysis of the Global Balantidiasis Market
In Europe, the prevalence of balantidiasis is found to be low which is attributed to stringent regulations governing the manufacturing of food products and low prevalence of gastrointestinal diseases.
In Asia Pacific, the prevalence of balantidiasis is found increasing steadily as a result of increasing prevalence of colitis, chronic diarrhea, and, deep intestinal ulcerations, poor healthcare system, and availability of treatment options for various gastrointestinal diseases.
According to the data from GLOBOCAN, in 2012, the age-standardized rate (ASR) of incidence of gastrointestinal diseases in Asia Pacific was 15.8 and mortality was 11.7 per 100,000. According to World Health Organization (WHO), the geriatric population in China in the year 2013 was 22.6 million which is expected to show a massive growth to 90.4 million in 2050.
BROWSE REPORT DETAILS AND IN-DEPTH TOC @ https://www.marketresearchfuture.com/reports/balantidiasis-market-4725
Some Points form Table of Content of Global Balantidiasis Market
Report Prologue
Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
..Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Balantidiasis Market Research and Development Strategy 2019 by Leading Industry Players - Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG here
News-ID: 1563841 • Views: …
More Releases from Market Research Future
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics.
The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over…
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more.
The Palm Methyl Ester Derivative Market Size was valued at USD 1.5…
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences.
Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2…
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further.
APAC Wallpaper Market Size was valued at USD 0.55…
More Releases for Balantidiasis
Balantidiasis Market 2019 Analysis by Treatment, Diagnosis and Research Advancem …
Market – Overview
Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human. Improper sanitary conditions and unsafe drinking water are important aspects for the spread of the diseases.
The global balantidiasis market is expected to grow at a CAGR of 2.1% during the forecast…
Balantidiasis Market Import | Export Outlook and Global Foresight 2023
Report Description
This report analyzes the global balantidiasis market by diagnosis (physical examination, stool examination, sigmoidoscopy, biopsy), by treatment (antibiotics, appendectomy), by end user (hospitals, clinics, diagnostic centers); it also studies the top manufacturers in the market.
The global balantidiasis market is projected to grow at a CAGR of around 2.1% during the forecast period.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3403768-balantidiasis-market-research-report-global-forecast-till-2023
The major players in global balantidiasis market include:
• Pfizer (U.S.)
• Abbott (U.S.)
• GlaxoSmithKline…
Balantidiasis Indsutry Overview 2018 - Rising Prevalence of Communicable Disease …
Market Highlights:
Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human. Improper sanitary conditions and unsafe drinking water are important aspects for the spread of the diseases.
The market is driven by the increasing prevalence of communicable diseases in rural areas for developing countries.…
Balantidiasis Market Research Segmented By Diagnosis, Treatment, End Users and G …
Global Balantidiasis Market growing at a CAGR of 3.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Definition: Global Balantidiasis Market
Balantidiasis also called as Balantidium coli infection, is a disease infected due to intestinal protozoan parasite Balantidium coli. The parasite enters through the fecal-oral…
Balantidiasis Market 2018 - Key Vendors are Pfizer (U.S.), Abbott (U.S.), GlaxoS …
Balantidiasis Market is expected to grow at a CAGR of 2.1% during the forecast period. The global balantidiasis market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, the market is segmented into stool examination, sigmoidoscopy, biopsy, and others. On the basis of treatment, the market is segmented into antibiotics, appendectomy, and others. Antibiotics segment is further divided into tetracycline, metronidazole, and others.…
Balantidiasis Market Research 2017: Demand, Application, Current Analysis and Gl …
The Global Balantidiasis Market accounted to USD xx million in 2017 growing at a CAGR of 3.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Definition: Global Balantidiasis Market
Balantidiasis also called as Balantidium coli infection, is a disease infected due to intestinal protozoan parasite Balantidium…
